Stay updated on Ligelizumab in CSU Japanese Patients Clinical Trial
Sign up to get notified when there's something new on the Ligelizumab in CSU Japanese Patients Clinical Trial page.

Latest updates to the Ligelizumab in CSU Japanese Patients Clinical Trial page
- CheckyesterdayChange DetectedRevision label updated to v3.5.0 and the previous label v3.4.3 was removed.SummaryDifference0.1%

- Check8 days agoChange DetectedThe page revision label was updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check16 days agoNo Change Detected
- Check23 days agoNo Change Detected
- Check37 days agoChange DetectedNew site revision (v3.4.2) and removal of an outdated funding/operating-status notice (v3.4.1) appear to be general site maintenance updates rather than changes to study content or critical functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check44 days agoChange DetectedAdded a site-wide notice about government funding lapse and open status, directing users to cc.nih.gov and opm.gov. Updated the page version from v3.4.0 to v3.4.1.SummaryDifference0.4%

- Check51 days agoChange DetectedCosmetic updates include adding a 'Show glossary' option, capitalization tweaks for QC-related labels (e.g., 'Last Update Submitted that Met QC Criteria'), a new 'No FEAR Act Data' label, and revision tag 'v3.4.0'. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check65 days agoChange DetectedThe page shows a minor revision update: v3.3.4 replaces v3.3.3, with no changes to the study details, eligibility criteria, or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Ligelizumab in CSU Japanese Patients Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ligelizumab in CSU Japanese Patients Clinical Trial page.